Literature DB >> 32735193

The Impact of Syringe Services Program Policy on Risk Behaviors Among Persons Who Inject Drugs in 3 US Cities, 2005-2015.

Tanner Nassau1, Alia Al-Tayyib2, William T Robinson3,4, Jennifer Shinefeld1, Kathleen A Brady1.   

Abstract

OBJECTIVES: The impact of a syringe services program (SSP) policy on risk behaviors and its durability are not as well studied as the impact of the SSPs themselves. We examined whether trends in syringe sharing among persons who inject drugs (PWID) were associated with changes to syringe access policies in 3 US cities: Denver, New Orleans, and Philadelphia.
METHODS: PWID were surveyed through National HIV Behavioral Surveillance System surveys in each city in 2005, 2009, 2012, and 2015. We assessed changes in syringe sharing from 2005 to 2015 by city. We used multivariable stepwise logistic regression analysis to measure the associations among syringe sharing and injection works sharing, time, and SSP access.
RESULTS: From 2005 to 2015, syringe sharing decreased significantly from 49.1% to 33.1% in Denver (P < .001), increased significantly from 32.0% to 50.5% in New Orleans (P < .001), and remained unchanged in Philadelphia (30.4% to 31.5%; P = .87). Compared with persons who obtained syringes from any nonsterile source, the adjusted odds of syringe sharing among PWID were significantly lower in each city if syringes were obtained from sterile sources only: Denver adjusted odds ratio (aOR) = 0.23 (95% confidence interval [CI], 0.18-0.30; New Orleans aOR = 0.26 (95% CI, 0.19-0.35), and Philadelphia aOR = 0.43 (95% CI, 0.33-0.57).
CONCLUSIONS: The lowest proportion of PWID reporting syringe sharing was in Philadelphia, which has a long-standing legal SSP. Implementation of a legal SSP in Denver in 2012 corresponded to a decrease in sharing, whereas the lack of a legal SSP in New Orleans corresponded to an increase in sharing. Universal long-term access to legal SSPs could further the progress made in HIV prevention among PWID.

Entities:  

Keywords:  NHBS; persons who inject drugs; syringe access; syringe service program policy; syringe sharing

Mesh:

Year:  2020        PMID: 32735193      PMCID: PMC7407040          DOI: 10.1177/0033354920930137

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  42 in total

1.  Evaluating effectiveness of syringe exchange programmes: current issues and future prospects.

Authors:  F I Bastos; S A Strathdee
Journal:  Soc Sci Med       Date:  2000-12       Impact factor: 4.634

2.  Geographic proximity, policy and utilization of syringe exchange programmes.

Authors:  R Rockwell; D C Des Jarlais; S R Friedman; T E Perlis; D Paone
Journal:  AIDS Care       Date:  1999-08

3.  Drug use and HIV risk practices of secondary and primary needle exchange users.

Authors:  Dezheng Huo; Susan L Bailey; Ronald C Hershow; Lawrence Ouellet
Journal:  AIDS Educ Prev       Date:  2005-04

4.  Evaluating consistency in repeat surveys of injection drug users recruited by respondent-driven sampling in the Seattle area: results from the NHBS-IDU1 and NHBS-IDU2 surveys.

Authors:  Richard D Burt; Hanne Thiede
Journal:  Ann Epidemiol       Date:  2012-03-14       Impact factor: 3.797

5.  Reduction of Injection-Related Risk Behaviors After Emergency Implementation of a Syringe Services Program During an HIV Outbreak.

Authors:  Monita R Patel; Carrie Foote; Joan Duwve; Erika Chapman; Brittany Combs; Alexandra Fry; Patti Hall; Jeremy Roseberry; John T Brooks; Dita Broz
Journal:  J Acquir Immune Defic Syndr       Date:  2018-04-01       Impact factor: 3.731

6.  Race and distance effects on regular syringe exchange program use and injection risks: a geobehavioral analysis.

Authors:  Chyvette T Williams; David S Metzger
Journal:  Am J Public Health       Date:  2010-04-15       Impact factor: 9.308

7.  Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015.

Authors:  Rose A Rudd; Puja Seth; Felicita David; Lawrence Scholl
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-12-30       Impact factor: 17.586

8.  Comparison of injection drug users accessing syringes from pharmacies, syringe exchange programs, and other syringe sources to inform targeted HIV prevention and intervention strategies.

Authors:  Abby E Rudolph; Natalie D Crawford; Danielle C Ompad; Ebele O Benjamin; Rachel J Stern; Crystal M Fuller
Journal:  J Am Pharm Assoc (2003)       Date:  2010 Mar-Apr 1

9.  Racial differences in acquisition of syringes from pharmacies under conditions of legal but restricted sales.

Authors:  Elizabeth C Costenbader; William A Zule; Curtis C Coomes
Journal:  Int J Drug Policy       Date:  2010-01-22

Review 10.  Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis.

Authors:  Esther J Aspinall; Dhanya Nambiar; David J Goldberg; Matthew Hickman; Amanda Weir; Eva Van Velzen; Norah Palmateer; Joseph S Doyle; Margaret E Hellard; Sharon J Hutchinson
Journal:  Int J Epidemiol       Date:  2013-12-27       Impact factor: 7.196

View more
  2 in total

1.  Policy and Public Health : Reducing the Burden of Infectious Diseases.

Authors:  Deron C Burton; Scott Burris; Jonathan H Mermin; David W Purcell; Sara C Zeigler; Lara Bull-Otterson; Hazel D Dean
Journal:  Public Health Rep       Date:  2020 Jul/Aug       Impact factor: 2.792

2.  Association Between Dual Partnership and Sexual and Injecting Behaviors Among Persons Who Inject Drugs in 23 US Cities, 2018.

Authors:  Xinyi Li; Patrick Sullivan; Dita Broz; Senad Handanagic
Journal:  Arch Sex Behav       Date:  2022-06-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.